Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon Cancer

<p>The purpose was to develop a metastatic score specific to the hepatic and peritoneal site in colorectal cancer patients from clinical, pathohistological and molecular markers potentially reflecting oncogenic activation (OA) or epithelial-mesenchymal transition (EMT), where OA may reflect an...

Full description

Bibliographic Details
Main Author: Christoph Wilmanns, Sandra Steinhauer, Joachim Grossmann, G&#252;nther Ruf
Format: Article
Language:English
Published: Ivyspring International Publisher 2009-01-01
Series:International Journal of Biological Sciences
Online Access:http://www.biolsci.org/v05p0458.htm
_version_ 1811339773989617664
author Christoph Wilmanns, Sandra Steinhauer, Joachim Grossmann, G&#252;nther Ruf
author_facet Christoph Wilmanns, Sandra Steinhauer, Joachim Grossmann, G&#252;nther Ruf
author_sort Christoph Wilmanns, Sandra Steinhauer, Joachim Grossmann, G&#252;nther Ruf
collection DOAJ
description <p>The purpose was to develop a metastatic score specific to the hepatic and peritoneal site in colorectal cancer patients from clinical, pathohistological and molecular markers potentially reflecting oncogenic activation (OA) or epithelial-mesenchymal transition (EMT), where OA may reflect an activation and EMT the functional loss of certain genes. The primary tumour stage (OA, EMT), lymphonodal stage (OA), the presence of a lymphangiosis carcinomatosa (OA), histological grade (OA, EMT), and immunoblot extraction of E-cadherin (OA, EMT) were differentially rated with zero to one or two points due to their potential contribution to each process and the resulting scores were validated in 27 colorectal cancer patients (three patients with pre-malignant adenomas, 16 with primaries and two with local recurrencies, three of which were metastatic to the peritoneum, six metastatic to the liver and two metastatic to both, the liver and the peritoneum, and five with hepatic secondaries, one of which at histology was metastatic to the peritoneum too). As a single parameter only the N-stage significantly contributed to OA (p&#60;0.05). Median OA and EMT scores, however, were 3.5 and 2 in the case of primaries without further spread, 5 and 4 in those nodal positive, 5 and 4 in the case of peritoneal implants, 6 and 2 in the case of liver metastases, and 6.5 and 3 in the case of a simultaneous hepatic and peritoneal spread, respectively. These differences were significant when scores from patients with and without liver metastases (OA, p&#60;0.002) or with peritoneal implants and isolated hepatic spread (EMT, p&#60;0.01) were compared. The results suggest a site-specific contribution of OA and EMT to tumour progression in human colon cancer.</p>
first_indexed 2024-04-13T18:32:22Z
format Article
id doaj.art-89ceb9c96ad9477aa013a4984233480a
institution Directory Open Access Journal
issn 1449-2288
language English
last_indexed 2024-04-13T18:32:22Z
publishDate 2009-01-01
publisher Ivyspring International Publisher
record_format Article
series International Journal of Biological Sciences
spelling doaj.art-89ceb9c96ad9477aa013a4984233480a2022-12-22T02:35:02ZengIvyspring International PublisherInternational Journal of Biological Sciences1449-22882009-01-0155458465Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon CancerChristoph Wilmanns, Sandra Steinhauer, Joachim Grossmann, G&#252;nther Ruf<p>The purpose was to develop a metastatic score specific to the hepatic and peritoneal site in colorectal cancer patients from clinical, pathohistological and molecular markers potentially reflecting oncogenic activation (OA) or epithelial-mesenchymal transition (EMT), where OA may reflect an activation and EMT the functional loss of certain genes. The primary tumour stage (OA, EMT), lymphonodal stage (OA), the presence of a lymphangiosis carcinomatosa (OA), histological grade (OA, EMT), and immunoblot extraction of E-cadherin (OA, EMT) were differentially rated with zero to one or two points due to their potential contribution to each process and the resulting scores were validated in 27 colorectal cancer patients (three patients with pre-malignant adenomas, 16 with primaries and two with local recurrencies, three of which were metastatic to the peritoneum, six metastatic to the liver and two metastatic to both, the liver and the peritoneum, and five with hepatic secondaries, one of which at histology was metastatic to the peritoneum too). As a single parameter only the N-stage significantly contributed to OA (p&#60;0.05). Median OA and EMT scores, however, were 3.5 and 2 in the case of primaries without further spread, 5 and 4 in those nodal positive, 5 and 4 in the case of peritoneal implants, 6 and 2 in the case of liver metastases, and 6.5 and 3 in the case of a simultaneous hepatic and peritoneal spread, respectively. These differences were significant when scores from patients with and without liver metastases (OA, p&#60;0.002) or with peritoneal implants and isolated hepatic spread (EMT, p&#60;0.01) were compared. The results suggest a site-specific contribution of OA and EMT to tumour progression in human colon cancer.</p>http://www.biolsci.org/v05p0458.htm
spellingShingle Christoph Wilmanns, Sandra Steinhauer, Joachim Grossmann, G&#252;nther Ruf
Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon Cancer
International Journal of Biological Sciences
title Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon Cancer
title_full Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon Cancer
title_fullStr Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon Cancer
title_full_unstemmed Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon Cancer
title_short Site-Dependent Differences in Clinical, Pathohistological, and Molecular Parameters in Metastatic Colon Cancer
title_sort site dependent differences in clinical pathohistological and molecular parameters in metastatic colon cancer
url http://www.biolsci.org/v05p0458.htm
work_keys_str_mv AT christophwilmannssandrasteinhauerjoachimgrossmanng252ntherruf sitedependentdifferencesinclinicalpathohistologicalandmolecularparametersinmetastaticcoloncancer